The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 20 (9) , 927-935
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor typeProceedings of the National Academy of Sciences, 2012
- Discovery of common variants associated with low TSH levels and thyroid cancer riskNature Genetics, 2012
- Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-β SignalingCell, 2011
- Structural basis for the cooperative DNA recognition by Smad4 MH1 dimersNucleic Acids Research, 2011
- High Throughput Determination of TGFβ1/SMAD3 Targets in A549 Lung Epithelial CellsPLOS ONE, 2011
- Sprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPARγ in Non–Small Cell Lung CancerMolecular Cancer Research, 2010
- Distinct Patterns of Expression and Evolution of Intronless and Intron-Containing Mammalian GenesMolecular Biology and Evolution, 2010
- Intronic enhancers coordinate epithelial-specific looping of the active CFTR locusProceedings of the National Academy of Sciences, 2009
- Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populationsNature Genetics, 2009
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004